European Archives - Page 680 of 1061 - European Medical Journal

Neutrophil-to-Lymphocyte Ratio and Corticosteroid Response in Alcoholic Hepatitis

Treatment of alcoholic hepatitis with corticosteroids remains controversial, with recent studies indicating only a 28-day survival benefit…

A Non-invasive Way of Detecting Alzheimer’s

ALZHEIMER’S disease could be tracked through a blood test, according to a new study. The results may prove to be the first step towards a new…

Antisense Treatment Shows Hope for Genetic Form of ALS

ALTHOUGH the cause of amyotrophic lateral sclerosis (ALS) is unknown, in 10% of cases it due to genetic mutations, many of which can be single nucleotide..

EMJ Oncology 7 [Suppl 1] 2019

This review covers the inherent difficulties in stratifying early-stage breast cancer patients with regard to risk of recurrence.

A Review of Gene Expression Profiling in Early-Stage ER+/HER2- Breast Cancer With A Focus on The PAM50 Risk of Recurrence Assay

Over 70% of patients with early-stage breast cancer are diagnosed with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative…

EMJ Neurology 7 [Suppl 1] 2019

Within this informative article, three major topics from the 34th ECTRIMS conference have been reviewed: i) the measurement and management of disease…

Current Issues in Multiple Sclerosis: Selected Highlights of the ECTRIMS 2018 Congress

It is well established that pregnancy has a clear impact on disease activity in multiple sclerosis (MS); the relapse rate decreases during…

Initial Success for a New Treatment for Autoimmune Diseases

With approximately 10% of Europeans living with an autoimmune disease,1 an effective and safe treatment is imperative. Now, in a human clinical trial…

New proteins identified could revolutionise muscle stem cell therapeutics

“We believe we have found promising drug targets that direct muscle stem cells to ‘make the right decision’ and stimulate muscle repair…

An interview with Thomas D'Hooghe from Merck

An interview with Thomas D’Hooghe, VP and Head Global Medical Affairs Fertility, Merck KGaA, Darmstadt, Germany at this year’s eyeforpharma, Barcelona Conference. We speak to Thomas about advancements in the fields of fertility and assisted reproductive technology as well as pharma’s role in providing world-class endometriosis care to all.